Temozolomide-related idiosyncratic and other uncommon toxicities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Temozolomide-related idiosyncratic and other uncommon toxicities

Published:2012-11 Issue:10 Volume:23 Page:1099-1106
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Dixit Sanjay,Baker Louise,Walmsley Vicki,Hingorani Mohan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference79 articles.

1. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.;Athanassiou;J Clin Oncol,2005

2. The safety of the temozolomide in patients with malignant glioma.;Dario;Curr Drug Saf,2006

3. Temozolomide in the treatment of solid tumours: current results and rationale for dosingscheduling.;Payne;Crit Rev Oncol Hematol,2005

4. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.;Stupp;N Engl J Med,2005

5. Fatal hematologic toxicity with prolonged continuous administration of temozolomide (TMZ) during radiation therapy (RT) in the treatment of newly-diagnosed glioblastoma multiforme (GBM): report of a phase II trial.;Doyle;J Clin Oncol,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive understanding of the adverse effects associated with temozolomide: a disproportionate analysis based on the FAERS database;Frontiers in Pharmacology;2024-08-23

2. Extended dosing (12 cycles) vs conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high-grade gliomas: a randomized, single-blind, two-arm, parallel-group controlled trial;Frontiers in Oncology;2024-05-07

3. Advances in Glioblastoma Therapy: An Update on Current Approaches;Brain Sciences;2023-10-31

4. Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta;Neuro-Oncology Practice;2023-10-27

5. Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells;Frontiers in Molecular Biosciences;2023-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3